1. Home
  2. MDGL vs LNC Comparison

MDGL vs LNC Comparison

Compare MDGL & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • LNC
  • Stock Information
  • Founded
  • MDGL 2011
  • LNC 1905
  • Country
  • MDGL United States
  • LNC United States
  • Employees
  • MDGL N/A
  • LNC N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • LNC Life Insurance
  • Sector
  • MDGL Health Care
  • LNC Finance
  • Exchange
  • MDGL Nasdaq
  • LNC Nasdaq
  • Market Cap
  • MDGL 6.8B
  • LNC 5.5B
  • IPO Year
  • MDGL N/A
  • LNC N/A
  • Fundamental
  • Price
  • MDGL $290.96
  • LNC $34.42
  • Analyst Decision
  • MDGL Strong Buy
  • LNC Hold
  • Analyst Count
  • MDGL 10
  • LNC 11
  • Target Price
  • MDGL $420.63
  • LNC $36.27
  • AVG Volume (30 Days)
  • MDGL 361.7K
  • LNC 1.9M
  • Earning Date
  • MDGL 05-01-2025
  • LNC 05-08-2025
  • Dividend Yield
  • MDGL N/A
  • LNC 5.23%
  • EPS Growth
  • MDGL N/A
  • LNC N/A
  • EPS
  • MDGL N/A
  • LNC 7.17
  • Revenue
  • MDGL $317,383,000.00
  • LNC $18,544,000,000.00
  • Revenue This Year
  • MDGL $264.55
  • LNC $5.25
  • Revenue Next Year
  • MDGL $67.21
  • LNC $1.94
  • P/E Ratio
  • MDGL N/A
  • LNC $4.80
  • Revenue Growth
  • MDGL N/A
  • LNC 54.56
  • 52 Week Low
  • MDGL $200.08
  • LNC $27.58
  • 52 Week High
  • MDGL $377.46
  • LNC $39.85
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.85
  • LNC 56.18
  • Support Level
  • MDGL $280.00
  • LNC $33.78
  • Resistance Level
  • MDGL $307.54
  • LNC $35.70
  • Average True Range (ATR)
  • MDGL 15.97
  • LNC 0.85
  • MACD
  • MDGL -2.00
  • LNC 0.32
  • Stochastic Oscillator
  • MDGL 15.88
  • LNC 72.29

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

Share on Social Networks: